The use of rapamycin in patients with tuberous sclerosis complex: Long-term results


Canpolat M., Gümüş H., Kumandaş S., Coşkun A., Per H.

EPILEPSY & BEHAVIOR, vol.88, pp.357-364, 2018 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 88
  • Publication Date: 2018
  • Doi Number: 10.1016/j.yebeh.2018.09.020
  • Journal Name: EPILEPSY & BEHAVIOR
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.357-364
  • Keywords: Rapamycin, Tuberous sclerosis, Epilepsy, mTOR, Child, GIANT-CELL ASTROCYTOMAS, MAMMALIAN TARGET, MTOR INHIBITORS, ADJUNCTIVE EVEROLIMUS, RISK-FACTORS, DOUBLE-BLIND, EPILEPSY, CHILDREN, MANAGEMENT, THERAPY

Abstract

Purpose: The purpose of this study was to evaluate the long-term results of eight cases diagnosed with tuberous sclerosis complex (TSC) and receiving rapamycin therapy because of epileptic seizures and/or accompanying TSC findings.